Table 3.
PR-interval/component* | Subgroup | HR (95%CI)† | P-value | P-interaction |
---|---|---|---|---|
Prolonged PR-interval | Age | |||
<54 years | 1.22 (0.88, 1.69) | 0.24 | 0.85 | |
≥54 years | 1.23 (1.02, 1.47) | 0.027 | ||
Sex | ||||
Female | 1.43 (1.14, 1.80) | 0.0021 | 0.033 | |
Male | 1.02 (0.82, 1.27) | 0.87 | ||
Race | ||||
Black | 1.08 (0.82, 1.44) | 0.58 | 0.31 | |
White | 1.25 (1.03, 1.51) | 0.025 | ||
| ||||
Prolonged P-wave | Age | |||
<54 years | 1.44 (1.03, 1.99) | 0.032 | 0.67 | |
≥54 years | 1.59 (1.32, 1.92) | <0.0001 | ||
Sex | ||||
Female | 1.79 (1.39, 2.31) | <0.0001 | 0.056 | |
Male | 1.34 (1.08, 1.65) | 0.0074 | ||
Race | ||||
Black | 1.67 (1.25, 2.24) | 0.0006 | 0.52 | |
White | 1.42 (1.17, 1.73) | 0.0005 | ||
| ||||
Prolonged P-wave onset to P-wave peak | Age | |||
<54 years | 1.33 (0.92, 1.92) | 0.13 | 0.54 | |
≥54 years | 1.79 (1.46, 2.20) | <0.0001 | ||
Sex | ||||
Female | 1.50 (1.13, 1.99) | 0.0048 | 0.70 | |
Male | 1.63 (1.29, 2.06) | <.0.0001 | ||
Race | ||||
Black | 1.48 (1.07, 2.05) | 0.018 | 0.45 | |
White | 1.64 (1.32, 2.03) | <0.0001 | ||
| ||||
Prolonged P-wave peak to P-wave end | Age | |||
<54 years | 1.23 (0.87, 1.75) | 0.25 | 0.38 | |
≥54 years | 1.18 (0.93, 1.49) | 0.17 | ||
Sex | ||||
Female | 1.30 (0.96, 1.75) | 0.090 | 0.42 | |
Male | 1.13 (0.87, 1.45) | 0.36 | ||
Race | ||||
Black | 1.12 (0.73, 1.74) | 0.60 | 0.78 | |
White | 1.22 (0.98, 1.51) | 0.078 | ||
| ||||
Prolonged PR-segment | Age | |||
<54 years | 1.27 (0.84, 1.90) | 0.26 | 0.42 | |
≥54 years | 1.02 (0.80, 1.29) | 0.91 | ||
Sex | ||||
Female | 1.24 (0.93, 1.65) | 0.14 | 0.12 | |
Male | 0.89 (0.65, 1.20) | 0.44 | ||
Race | ||||
Black | 0.88 (0.60, 1.30) | 0.53 | 0.21 | |
White | 1.14 (0.89, 1.46) | 0.30 |
PR-interval >200 ms and PR-interval component values >95th percentile of their distribution.
HRs are presented for abnormal P-wave indices compared with those who had normal values. Model adjusted for age, sex, race, body mass index, heart rate, systolic blood pressure, smoking, diabetes, low-density lipoprotein cholesterol, coronary heart disease, and heart failure.
AF=atrial fibrillation; CI=confidence interval; HR=hazard ratio.